Faculty Opinions recommendation of Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial.

2018 ◽  
Author(s):  
Eivind Berge
Keyword(s):  
Randomised Controlled Trial ◽  
Acute Stroke ◽  
Functional Outcomes ◽  
Controlled Trial ◽  
Double Blind ◽  
Randomised Controlled

scholarly journals Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial

The Lancet ◽  
2019 ◽  
Vol 393 (10168) ◽  
pp. 265-274 ◽  
Author(s):  
Martin Dennis ◽  
Gillian Mead ◽  
John Forbes ◽  
Catriona Graham ◽  
Maree Hackett ◽  
...  
Keyword(s):  
Randomised Controlled Trial ◽  
Acute Stroke ◽  
Functional Outcomes ◽  
Controlled Trial ◽  
Double Blind ◽  
Randomised Controlled

Does fluoxetine improve recovery after stroke?

BMJ ◽  
2019 ◽  
pp. l1029
Author(s):  
Rob Cook ◽  
Vaughan Thomas ◽  
Rosie Martin
Keyword(s):  
Randomised Controlled Trial ◽  
Health Technology Assessment ◽  
Technology Assessment ◽  
Functional Outcomes ◽  
Controlled Trial ◽  
Health Technology ◽  
Double Blind ◽  
Health Technology Assessment Programme ◽  
Randomised Controlled ◽  
The Uk

The study FOCUS Trial Collaboration. Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial. Lancet 2019;393:256-74. The study was funded by the UK Stroke Association and the NIHR Health Technology Assessment Programme project number 13/04/30. To read the full NIHR Signal, go to: https://discover.dc.nihr.ac.uk/content/signal-000729/a-commonly-used-antidepressant-doesnt-improve-recovery-after-stroke

Sign in / Sign up

Export Citation Format

Share Document